Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 11Lymphoma, Mantle-Cell 10Leukemia, Lymphocytic, Chronic, B-Cell 6Lymphoma, Follicular 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, B-Cell, Marginal Zone 4Lymphoma, B-Cell 4Burkitt Lymphoma 3Leukemia, Myeloid, Accelerated Phase 2Leukemia, Biphenotypic, Acute 2Blast Crisis 2Waldenstrom Macroglobulinemia 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, AIDS-Related 1Leukemia, Prolymphocytic 1Leukemia, Myeloid, Acute 1Composite Lymphoma 1Anemia 1

Interventions

Rituximab 6ibrutinib 4venetoclax 3acalabrutinib 3zanubrutinib 2pirtobrutinib 2fludarabine phosphate 2Whole-Body Irradiation 2Sirolimus 2Mycophenolic Acid 2Melphalan 2Cyclophosphamide 2Bortezomib 2Bendamustine Hydrochloride 2selinexor 1loncastuximab tesirine 1ixazomib 1carfilzomib 1Valganciclovir 1Valacyclovir 1Therapeutics 1Tacrolimus 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Methotrexate 1Lenalidomide 1Ganciclovir 1Foscarnet 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Waldenstrom Macroglobulinemia × CT-P10 × Clear all
NCT02339922 2026-03-05

Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma

University of Washington

Phase 2 Active not recruiting
33 enrolled 16 charts
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡